ATA284985A - Verfahren zur herstellung von neuen carbapenemderivaten - Google Patents

Verfahren zur herstellung von neuen carbapenemderivaten

Info

Publication number
ATA284985A
ATA284985A AT0284985A AT284985A ATA284985A AT A284985 A ATA284985 A AT A284985A AT 0284985 A AT0284985 A AT 0284985A AT 284985 A AT284985 A AT 284985A AT A284985 A ATA284985 A AT A284985A
Authority
AT
Austria
Prior art keywords
carbapene
derivatives
producing new
producing
new
Prior art date
Application number
AT0284985A
Other languages
English (en)
Other versions
AT395151B (de
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to AT0341587A priority Critical patent/AT396473B/de
Publication of ATA284985A publication Critical patent/ATA284985A/de
Application granted granted Critical
Publication of AT395151B publication Critical patent/AT395151B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0284985A 1984-10-02 1985-10-02 Verfahren zur herstellung von neuen carbapenemderivaten AT395151B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0341587A AT396473B (de) 1984-10-02 1987-12-23 Verfahren zur herstellung von neuen carbapenemderivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/656,838 US4683301A (en) 1982-04-08 1984-10-02 Carbapenem antibiotics

Publications (2)

Publication Number Publication Date
ATA284985A true ATA284985A (de) 1992-02-15
AT395151B AT395151B (de) 1992-10-12

Family

ID=24634788

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0284985A AT395151B (de) 1984-10-02 1985-10-02 Verfahren zur herstellung von neuen carbapenemderivaten

Country Status (24)

Country Link
US (1) US4683301A (de)
JP (1) JPS6187682A (de)
KR (1) KR910009270B1 (de)
AT (1) AT395151B (de)
AU (1) AU575432B2 (de)
BE (1) BE903353A (de)
CA (1) CA1260945A (de)
CH (1) CH665640A5 (de)
DE (1) DE3535196A1 (de)
DK (1) DK446685A (de)
ES (2) ES8703880A1 (de)
FI (1) FI79317C (de)
FR (1) FR2571054B1 (de)
GB (1) GB2165247B (de)
GR (1) GR852336B (de)
HU (1) HU194240B (de)
IL (1) IL76539A0 (de)
IT (1) IT1190396B (de)
LU (1) LU86105A1 (de)
NL (1) NL8502681A (de)
OA (1) OA08113A (de)
PT (1) PT81236B (de)
SE (1) SE466202B (de)
ZA (1) ZA857581B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
US5116833A (en) * 1990-10-19 1992-05-26 Bristol-Myers Squibb Company Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof
AR002507A1 (es) * 1995-06-28 1998-03-25 Merck & Co Inc Proceso mejorado para sintetizar intermediarios de carbapenem
US5823718A (en) * 1996-07-25 1998-10-20 Alnet (Proprietary) Limited Pillar bag

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4235920A (en) * 1975-11-21 1980-11-25 Merck & Co., Inc. N-Alkylated derivatives of thienamycin
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
US4218463A (en) * 1977-12-28 1980-08-19 Merck & Co., Inc. 3-Substituted thio-6-amido-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
US4174316A (en) * 1978-08-14 1979-11-13 Merck & Co., Inc. 4-Iodomethylazetidin-2-one
DE2966497D1 (en) * 1978-10-24 1984-01-26 Merck & Co Inc 6-, 1- and 2-substituted-1-carbapen-2-em-3-carboxylic acids, processes for the preparation of such compounds and pharmaceutical composition comprising such compounds
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4318912A (en) * 1979-01-02 1982-03-09 Merck & Co., Inc. 6-(1-Hydroxyethyl)-3-substituted-1-azabicyclo(3.2.0)-hept-2-en-7-one-2-carboxylic acid
DK165280A (da) * 1979-04-19 1980-10-20 Merck & Co Inc Fremgangsmaade til fremstilling af 2- og 6-substituerede 1-carbadethiapen-2-em-3-carboxylsyrer og mellemprodukter til brug ved udoevelse af fremgangsmaaden
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
EP0055990B1 (de) * 1979-08-10 1986-06-11 Beecham Group Plc Beta-Lactam-Antibiotika, ihre Herstellung und Verwendung
US4309346A (en) * 1980-03-27 1982-01-05 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via trithioorthoacetates
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0037082B1 (de) * 1980-03-27 1985-03-20 Merck & Co. Inc. Verfahren zur Herstellung von 1-Carbapenem-Derivaten und von Zwischenprodukten via silyl-substituierter Dithioacetale
EP0038869A1 (de) * 1980-04-30 1981-11-04 Merck & Co. Inc. Verfahren zur Herstellung von 1-Carbapenemen und Zwischenprodukte für ihre Herstellung
JPS56161393A (en) * 1980-05-16 1981-12-11 Sanraku Inc Beta-lactam compound
US4378315A (en) * 1980-05-29 1983-03-29 Merck & Co., Inc. Process for the preparation of thienamycin and intermediates
US4350631A (en) * 1980-12-18 1982-09-21 Merck & Co., Inc. 6- and 4-Substituted-1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylates
ES514240A0 (es) * 1981-08-03 1984-04-16 Merck & Co Inc Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
EP0074599A1 (de) * 1981-09-09 1983-03-23 Takeda Chemical Industries, Ltd. 5,6-Cis-Carbapenem-Derivate, ihre Herstellung und Verwendung
US4640915A (en) * 1982-03-29 1987-02-03 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives
CA1198440A (en) * 1982-04-08 1985-12-24 Choung U. Kim Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
EP0113101A1 (de) * 1982-12-30 1984-07-11 Merck & Co. Inc. 6-(1-Hydroxyäthyl)-2-SR8-1-methyl-1-carbadethiapen-2-em-3-carbonsäureester
AR241016A1 (es) * 1983-03-08 1991-04-30 Bristol Myeres Squibb Company "derivados de aminotiol cuaternario, procedimiento para prepararlos y procedimiento para preparar compuestos de carbapenem a partir de dichos derivados".

Also Published As

Publication number Publication date
FR2571054A1 (fr) 1986-04-04
HU194240B (en) 1988-01-28
ES553605A0 (es) 1987-11-01
GR852336B (de) 1986-02-04
OA08113A (fr) 1987-03-31
IT8522317A0 (it) 1985-10-01
DE3535196A1 (de) 1986-04-10
PT81236B (pt) 1988-02-17
FI853748A0 (fi) 1985-09-27
GB2165247B (en) 1988-08-10
GB8524125D0 (en) 1985-11-06
BE903353A (fr) 1986-04-01
FI79317C (fi) 1989-12-11
CA1260945A (en) 1989-09-26
ES547438A0 (es) 1987-03-01
KR910009270B1 (ko) 1991-11-08
AU4810285A (en) 1986-04-10
DK446685A (da) 1986-04-03
AT395151B (de) 1992-10-12
AU575432B2 (en) 1988-07-28
US4683301A (en) 1987-07-28
NL8502681A (nl) 1986-05-01
JPS6187682A (ja) 1986-05-06
ES8800223A1 (es) 1987-11-01
KR860003257A (ko) 1986-05-21
SE466202B (sv) 1992-01-13
CH665640A5 (de) 1988-05-31
ZA857581B (en) 1986-05-28
LU86105A1 (fr) 1986-06-11
IL76539A0 (en) 1986-02-28
IT1190396B (it) 1988-02-16
FI79317B (fi) 1989-08-31
FR2571054B1 (fr) 1988-09-30
FI853748L (fi) 1986-04-03
SE8504538L (sv) 1986-04-03
DK446685D0 (da) 1985-10-01
ES8703880A1 (es) 1987-03-01
SE8504538D0 (sv) 1985-10-01
GB2165247A (en) 1986-04-09
HUT38641A (en) 1986-06-30
PT81236A (en) 1985-11-01

Similar Documents

Publication Publication Date Title
ATA20485A (de) Verfahren zur herstellung von neuen tetrahydrocarbazol-derivaten
ATA28687A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
ATA251585A (de) Verfahren zur herstellung von neuen ethylendiaminmonoamid-derivaten
AT381091B (de) Verfahren zur herstellung von neuen ergolinderivaten
ATA5985A (de) Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen
AT386197B (de) Verfahren zur herstellung von neuen indolderivaten
ATA404284A (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
AT385035B (de) Verfahren zur herstellung von neuen ergolinderivaten
ATA273486A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
ATA258985A (de) Verfahren zur herstellung von neuen substituierten 7-oxomitosanen
AT380477B (de) Verfahren zur herstellung von neuen spirothiazolidindion-derivaten
AT384218B (de) Verfahren zur herstellung von neuen chinazolin-derivaten
ATA313686A (de) Verfahren zur herstellung von neuen carbapenemderivaten
ATA298586A (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
ATA106084A (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
ATA284985A (de) Verfahren zur herstellung von neuen carbapenemderivaten
ATA52285A (de) Verfahren zur herstellung von neuen diazepinoindolen
AT386407B (de) Verfahren zur herstellung von neuen n-sulfamyl -3-halogenpropionamidinen
AT377264B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT381318B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT386410B (de) Verfahren zur herstellung von neuen ergolinderivaten
ATA294685A (de) Verfahren zur herstellung von neuen nucleosidderivaten
ATA341587A (de) Verfahren zur herstellung von neuen carbapenemderivaten
AT389508B (de) Verfahren zur herstellung von neuen 2-acetylthiomethyl-3-benzoylpropionsaeurederivat n
ATA224888A (de) Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee